Consistently, the mERG/EZH2 gene set (n = 540), was functionally associated with oncogenic pathways and features enriched in cancer most of them overlapping with the ERG/EZH2 gene set (Supplementary Fig. 8a, b). This evidence concerns the gene EZH2 and cancer.